Persistent symptoms at the end of 3 months after Acute COVID-19 infection among adult patients admitted to a tertiary care centre: A descriptive longitudinal study

  • Priyanka H Salunke Senior Resident, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Varsharani V Kendre Associate Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Malangori A Parande Associate Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Ashwini U Patekar Assistant Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Muralidhar P Tambe Professor and Head, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Yallapa UJadhav Associate Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Ganesh R Jagdale Medical Officer, Pune Municipal Corporation, Pune, India.
  • Minal Hatnapure Junior Resident, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Pradip Borle Statistician cum Assistant Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Pradnya V Shinde Assistant Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Namrata D Mule Assistant Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Rupali N Baviskar Assistant Professor, Department of Community Medicine, B J Government Medical College, Pune, India.
  • Shubham S Pardeshi Junior Resident, Department of Community Medicine, B J Government Medical College, Pune, India.
Keywords: Acute Covid-19, Persistent symptoms, longitudinal study, Post-COVID-19

Abstract

Background: COVID-19 has affected all corners of the world. Multiple symptoms reported during the hospital stay may persist after the patient discharged from the hospital. Objectives: 1) To study the persistence of symptoms at the end of 3 months after acute COVID-19 infection among adult patients admitted to a tertiary care centre. 2) To review their symptoms during the acute COVID-19 infection. 3) To study the association between various factors and the persistence of symptoms of acute COVID-19 infection.
Material & Method: This was a descriptive longitudinal study conducted in November 2021. The sample included 200 laboratory-confirmed COVID-19 cases discharged from the tertiary care hospital of Pune City after obtaining written informed consent.Epidemiological information was obtained by telephonic interview with predesigned and pretested proforma covering socio-demographic data, related factors and information about the onset and duration of symptoms after the patient was discharged from the hospital.
Results: The study involved 200 recovered COVID-19 patients (115 males, 85 females) with a mean age of 46.42 ± 16.22 years. Notably, 90% of males had some form of addiction, compared to 10% of females, revealing a significant gender disparity (p value <0.0001). Fatigue (75.50%), cough (73%), and fever > 38.0 OC(69.50%) were prevalent persistent symptoms. A statistically significant association of persistence of symptoms was found with age and COVID-19 vaccination status.
Conclusion: Our study provides crucial insights into long-term COVID-19 symptoms, advocating targeted interventions considering demographic factors. This comprehensive approach guides effective management of persistent symptoms post-COVID-19.

Salunke P H, Kendre V V, Parande M A, Patekar A
U, Tambe M P, Jadhav Y U, Jagdale G R, Hatnapure
M, Borle P, Shinde P V, Mule N D, Baviskar R N,
Pardeshi S S. Persistent Symptoms at the End of
3 Months after Acute COVID-19 Infection among
Adult Patients Admitted to a Tertiary Care Centre:
A Descriptive Longitudinal Study. J Commun Dis.
2024;56(3):119-126.

DOI: https://doi.org/10.24321/0019.5138.202456

References

Worldometer [Internet]. India: Coronavirus cases; [cited 2024 Apr 11]. Available from: https://www.

worldometers.info/coronavirus/country/india/

Johns Hopkins University and Medicine [Internet]. Ongoing Johns Hopkins COVID-19 resources; [cited

Jun 1]. Available from: https://coronavirus.jhu.edu/

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, Zeng G, Yuen KY,

Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng

P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment

Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med.

;382(18):1708-20. [PubMed] [Google Scholar]

Carfi A, Bernabei R, Landi F; Gemelli Against COVID-19

Post-Acute Care Study Group. Persistent symptoms in

patients after acute COVID-19. JAMA. 2020;324(6):603-

[PubMed] [Google Scholar]

Goertz YM, Van Herck M, Delbressine JM, Vaes AW, MEYS R, Machado FV, Houben-Wilke S, Burtin

C, Posthuma R, Franssen FM, Loon NV, Hajian B, Spies Y, Vijlbrief H, Hul AJ, Janssen DJ, Spruit MA.

Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open

Res. 2020;6(4):00542-2020. [PubMed] [Google Scholar]

Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A Review of Persistent Post-COVID

Syndrome (PPSC). Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74. [PubMed] [Google Scholar]

National Institute for Health and Care Excellence [Internet]. COVID-19 rapid guideline: managing the

long-term effects of COVID-19; 2020 [cited 2024 Apr 10]. Available from: https://www.nice.org.uk/

guidance/ng188

Ayoudkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. PostCOVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ.

;372:n693. [PubMed] [Google Scholar]

MyGov [Internet]. https://www.mygov.in/covid-19accessed on 1 June 2021

Pune Municipal Corporation [Internet]. Available from: https://www.pmc.gov.in accessed on 1 June 2021

Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline

HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID,

Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators.

Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19

in a multistate healthcare systems network- United States, March-June 2020. MMWR Morb Mortal Wkly

Rep. 2020;69(30):993-8. [PubMed] [Google Scholar]

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas

LS, Molteni E, Modat M, Cardoso MJ, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi

AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FM, Franks PW, Chan AT, Wolf

J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626-

[PubMed] [Google Scholar]

National Institute for Health and Care Excellence [Internet]. [cited 2023 Dec 9]. Available from:

https://www.nice.org.uk/guidence/cg53/chapter/1-Guidance#diagnosis

Hempel S, Chambers D, Bagnall AM, Forbes C. Risk factors for chronic fatigue syndrome/myalgic

encephalomyelitis: a systematic scoping review of multiple predictor studies. Psychol Med.

;38(7):915. [PubMed] [Google Scholar]

Chen FJ, Li FR, Zheng JZ, Zhou R, Liu HM, Wu KY, Zhang B, Dong H, Lu JY, Lei CL, Wu XB. Factors associated

with duration of hospital stay and complications in patients with COVID-19. J Public Health Emerg.

;5:6. [Google Scholar]

Published
2024-10-08